Showing results (1-10 of 36) with videos related to
Sort By:
Pageof 4
Hematological Oncology|June 9, 2021
Molecular classification of aggressive lymphomas-past, present, futureKirsty Wienand, Björn ChapuyDeutsche Medizinische Wochenschrift (1946)|May 15, 2024
[Malignant lymphomas - quo vadis? - What developments await us in diagnostics and therapy?]Stefan Alig, Christiane Pott, Björn ChapuyMedizinische Klinik (Munich, Germany : 1983)|May 11, 2006
[Mesenchymal stem cells from bone marrow. Phenotype, aspects of biology, and clinical perspectives]Gerald G Wulf, Björn Chapuy, Lorenz TrümperBiomedicines|November 27, 2021
Patient-Specific Modeling of Diffuse Large B-Cell LymphomaKirsten Thobe, Fabian Konrath, Björn Chapuy, et al.NAR Genomics and Bioinformatics|February 3, 2025
Advancing personalized cancer therapy: Onko_DrugCombScreen-a novel Shiny app for precision drug combination screeningJingyu Yang, Meng Wang, Jürgen Dönitz, et al.Histopathology|November 15, 2024
Evolving molecular classification of aggressive B-cell lymphomaStefan K Alig, Björn Chapuy, Daisuke Ennishi, et al.Traffic (Copenhagen, Denmark)|April 16, 2008
AP-1 and AP-3 mediate sorting of melanosomal and lysosomal membrane proteins into distinct post-Golgi trafficking pathwaysBjörn Chapuy, Ritva Tikkanen, Chris Mühlhausen, et al.Vaccine|May 19, 2009
Characterization of HLA-DR-restricted T-cell epitopes derived from human proteinase 3Matthias Piesche, York Hildebrandt, Björn Chapuy, et al.Human Immunology|June 23, 2007
Identification of a promiscuous HLA DR-restricted T-cell epitope derived from the inhibitor of apoptosis protein survivinMatthias Piesche, York Hildebrandt, Florian Zettl, et al.Annals of Hematology|May 12, 2016
Modified BEAM with triple autologous stem cell transplantation for patients with relapsed aggressive non-Hodgkin lymphomaKarin Hohloch, Samira Zeynalova, Björn Chapuy, et al.Pageof 4